Literature DB >> 25102523

Viscosupplementation for treating osteoarthritis in the military population.

Michael J Langworthy1, Fred Nelson2, Brett D Owens3.   

Abstract

Military personnel have a greater risk of developing osteoarthritis (OA) than the general population. OA is a chronic, painful, and debilitating disease with a high cost burden. Compared with the general population, a higher prevalence of post-traumatic OA has been reported in the military. Using recent literature, we aim to improve the understanding of post-traumatic OA, with an exploration of the pathophysiology of OA. Our review encompasses the current treatment modalities for alleviating the pain from OA with a focus on viscosupplementation. A multimodal approach may be beneficial for the relief of OA pain and improvement of function in military personnel with early OA, and may lower the cost burden. Reprint &
Copyright © 2014 Association of Military Surgeons of the U.S.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 25102523     DOI: 10.7205/MILMED-D-14-00052

Source DB:  PubMed          Journal:  Mil Med        ISSN: 0026-4075            Impact factor:   1.437


  3 in total

1.  Efficacy of Triamcinolone Acetonide Extended-Release in Participants with Unilateral Knee Osteoarthritis: A Post Hoc Analysis.

Authors:  Michael J Langworthy; Philip G Conaghan; Joseph J Ruane; Alan J Kivitz; Joelle Lufkin; Amy Cinar; Scott D Kelley
Journal:  Adv Ther       Date:  2019-04-09       Impact factor: 3.845

Review 2.  The Value of Phenotypes in Knee Osteoarthritis Research.

Authors:  Fred R T Nelson
Journal:  Open Orthop J       Date:  2018-03-16

3.  Treat-to-target strategy for knee osteoarthritis. International technical expert panel consensus and good clinical practice statements.

Authors:  Alberto Migliore; Gianfranco Gigliucci; Liudmila Alekseeva; Sachin Avasthi; Raveendhara R Bannuru; Xavier Chevalier; Thierry Conrozier; Sergio Crimaldi; Nemanja Damjanov; Gustavo Constantino de Campos; Demirhan Diracoglu; Gabriel Herrero-Beaumont; Giovanni Iolascon; Ruxandra Ionescu; Natasa Isailovic; Jörg Jerosch; Jorge Lains; Emmanuel Maheu; Souzi Makri; Natalia Martusevich; Marco Matucci Cerinc; Mihaela Micu; Karel Pavelka; Robert J Petrella; Umberto Tarantino; Raghu Raman
Journal:  Ther Adv Musculoskelet Dis       Date:  2019-12-19       Impact factor: 5.346

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.